TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataKi: 7nMAssay Description:Binding affinity of the compound in Cholecystokinin type A receptor binding assay (iv) in miceMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataKi: 9nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 0.470nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 1(RAT)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 1 in ratMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 4.10nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 8.30nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 4(RAT)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 4More data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(RAT)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 2More data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 1(RAT)
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against NPY1 (Neuropeptide Y receptor type 1)More data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 60nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 6.30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 0.0600nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 0.430nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 6.30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataEC50: 300nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair